Tirzepatide is a GLP-1 and GIP receptor agonist, meaning it mimics natural hormones in the body to Regulate blood sugar levels, Suppress appetite, Enhance metabolism, Improve insulin sensitivity, and encourage the body to use stored fat for energy
It is the only company in the US with Food and Drug Administration (FDA) approval for products containing semaglutide
425,426 In a murine model of AD, the administration of GLP-1RAs effectively reduced the levels of pathological markers associated with AD
[] Semaglutide was initially approved by the US Food and Drug Administration in 2017 for the treatment of type 2 diabetes
Alexander Shapsis, MD, Board-Certified Specialist in Gastroenterology and Obesity Medicine Key Takeaways The Frustration of the Silent Scale Youve done the work